Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration.
about
Current and emerging treatment options for myopic choroidal neovascularizationCorneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone.Drug delivery to the eye: what benefits do nanocarriers offer?Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases.How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.
P2860
Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Triamcinolone acetonide nanopa ...... -related macular degeneration.
@en
type
label
Triamcinolone acetonide nanopa ...... -related macular degeneration.
@en
prefLabel
Triamcinolone acetonide nanopa ...... -related macular degeneration.
@en
P2093
P2860
P1476
Triamcinolone acetonide nanopa ...... -related macular degeneration.
@en
P2093
Aditya Grover
Anjali Hirani
Vijaykumar Sutariya
Yashwant Pathak
Yong W Lee
P2860
P356
10.3109/10837450.2014.965326
P577
2014-09-26T00:00:00Z